807 results on '"Branch, D. Ware"'
Search Results
2. Progress in APS pregnancy: Results from the IMPACT trial
3. Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)
4. Deciphering the clinical significance of longitudinal antiphospholipid antibody titers
5. How I diagnose and treat antiphospholipid syndrome in pregnancy
6. Excluding pregnancy-associated deep vein thrombosis with whole-leg ultrasound
7. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study
8. Association Between Novel Antiphospholipid Antibodies and Adverse Pregnancy Outcomes.
9. Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial
10. Ultrasonography of the Explanted Uterus in Placenta Accreta Spectrum: Correlation With Intraoperative Findings and Gross Pathology
11. Oxytocin is not associated with postpartum hemorrhage in labor augmentation in a retrospective cohort study in the United States
12. Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III‐D Report: Multicriteria Decision Analysis.
13. Antiphospholipid syndrome: Diagnosis and management in the obstetric patient
14. 51 - Collagen Vascular Diseases in Pregnancy
15. Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository
16. The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort
17. Trends in Unplanned Peripartum Hysterectomy in the United States, 2009–2020
18. Reply
19. The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis
20. Clinical Implications of Anti-Phospholipid Antibodies: The Utah Experience
21. Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria
22. Prevention and Treatment of Obstetric Antiphospholipid Syndrome
23. HOW I DIAGNOSE AND TREAT ANTIPHOSPHOLIPID SYNDROME IN PREGNANCY
24. Thrombotic markers in pregnant patients with and without SARS-CoV-2 infection
25. Antiphospholipid Syndrome: Management of the Obstetric Patient
26. In Reply
27. Cost of Elective Labor Induction Compared With Expectant Management in Nulliparous Women
28. Placenta Accreta Spectrum Disorder: Uterine Dehiscence, Not Placental Invasion
29. Excluding pregnancy-associated DVT with whole-leg ultrasound
30. 2023 ACR/EULAR antiphospholipid syndrome classification criteria
31. P1637: PROTEOMIC PROFILING OF DIFFERENT ANTIPHOSPHOLIPID ANTIBODY-POSITIVE PHENOTYPES: RESULTS FROM ANTIPHOSPHOLIPID SYNDROME ALLIANCE FOR CLINICAL TRIALS AND INTERNATIONAL NETWORKING (APS ACTION) REGISTRY
32. Oxytocin is not associated with postpartum hemorrhage in labor augmentation in a retrospective cohort study in the United States
33. The Epitopes for Some Antiphospholipid Antibodies are Adducts of Oxidized Phospholipid and β 2 Glycoprotein 1 (and Other Proteins)
34. Anticardiolipin Antibodies From Patients With the Antiphospholipid Antibody Syndrome Recognize Epitopes in Both β2-Glycoprotein 1 and Oxidized Low-Density Lipoprotein
35. Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus
36. The hidden world of anti-phospholipid antibodies and female infertility: A literature appraisal
37. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and β2 glycoprotein 1 (and other proteins)
38. Low frequency of flares during pregnancy and post-partum in stable lupus patients
39. Placenta accreta spectrum: biomarker discovery using plasma proteomics
40. Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.
41. Targeting a higher plasma VWF level at time of delivery in pregnant individuals with von Willebrand disease: Outcomes at a single‐institution cohort study.
42. The Effect of "Off Hours" on Maternal and Perinatal Outcomes in a Diverse U.S. Cohort.
43. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An APS ACTION Study
44. Normal Pregnancy, Pregnancy Complications, and Obstetric Management
45. Prevalence of antiphospholipid antibodies and risk of subsequent adverse obstetric outcomes in women with prior pregnancy loss
46. Contributors
47. Task Force Report on Obstetric Antiphospholipid Syndrome
48. Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management
49. Whole-genome sequencing analysis in families with recurrent pregnancy loss: A pilot study
50. Fetal and maternal morbidity in pregnant patients with Lupus: a 10-year US nationwide analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.